fbpx
June 5, 2020

Cannabis Misconceptions Still Common Among MS Clinicians Cannabis Misconceptions Still Common Among MS Clinicians

Despite the ever-increasing acceptance of medical cannabis and its notably common use in patients with multiple sclerosis (MS), clinicians treating those patients still may be poorly […]
June 5, 2020

Newest Oral DMTs Haven’t Yet Made a Big Impact in the MS World Newest Oral DMTs Haven’t Yet Made a Big Impact in the MS World

The three oral disease-modifying therapies (DMTs) for multiple sclerosis (MS) approved last year in the United States haven’t made a big splash in the marketplace. So […]
June 5, 2020

‘Paralyzing Agent’ Warning Missing on Neuromuscular Blockers ‘Paralyzing Agent’ Warning Missing on Neuromuscular Blockers

The US Food and Drug Administration (FDA) is notifying healthcare providers about the temporary absence of the words “paralyzing agent” on the vial caps of two […]
June 4, 2020

Hyperbaric Oxygen Tx Eases Persistent Postconcussion Symptoms Hyperbaric Oxygen Tx Eases Persistent Postconcussion Symptoms

Hyperbaric oxygen therapy (HBOT) markedly reduces multiple symptoms of persistent postconcussion syndrome (PPCS) following mild traumatic brain injury (mTBI), results from a randomized controlled crossover study […]
June 4, 2020

Herpes Zoster Infection With MS Treatment Higher in Women? Herpes Zoster Infection With MS Treatment Higher in Women?

Reports of herpes zoster virus (HZV) among patients being treated with disease-modifying therapies (DMTs) for multiple sclerosis (MS) are nearly 5 times higher among women vs […]
June 3, 2020

COVID-19: Does Virus Directly Attack the Brain? COVID-19: Does Virus Directly Attack the Brain?

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s  Coronavirus Resource Center. Neurologic effects can be a significant part of COVID-19, but does the […]
June 2, 2020

MOMENTUM: Combination Product Shows Promise in Migraine MOMENTUM: Combination Product Shows Promise in Migraine

A new combination product comprising the triptan rizatriptan and the nonsteroidal anti-inflammatory drug (NSAID) meloxicam has shown promising results in the treatment of migraine. In the […]
June 2, 2020

Cannabis Gaining Acceptance as Treatment for Neuropathic Pain? Cannabis Gaining Acceptance as Treatment for Neuropathic Pain?

Experts may be moving toward accepting cannabis as a useful tool to treat neuropathic pain (NP), a recent debate on the topic suggests. During the debate, […]
June 1, 2020

Medtronic’s StealthStation DBS Software Subject of Class I Recall Medtronic’s StealthStation DBS Software Subject of Class I Recall

Medtronic has recalled the auto-registration feature in the StealthStation deep brain stimulation (DBS) software because of inaccuracies during DBS procedures, according to a notice on the […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0